Home/Filings/4/0001140361-22-013064
4//SEC Filing

Benton Susan 4

Accession 0001140361-22-013064

CIK 0001228627other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 9:16 AM ET

Size

4.9 KB

Accession

0001140361-22-013064

Insider Transaction Report

Form 4
Period: 2022-04-01
Benton Susan
Director
Transactions
  • Award

    Common Stock

    2022-04-01+3,39532,455 total
Footnotes (1)
  • [F1]The Reporting Person was granted shares of common stock in lieu of cash for board services for the first quarter of 2022. The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share). The fair market value was $3.24 per share, the closing price of the common stock on March 31, 2022.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001373649

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:16 AM ET
Size
4.9 KB